Bioluminescent imaging: Emerging technology for non-invasive imaging of bone tissue engineering

Biomaterials

Volumn 27, Issue 9, 2006, Pages 1851-1858

  De Boer, Jan ^a   Van Blitterswijk, Clemens ^a   Löwik, Clemens ^b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone tissue engineering; Molecular imaging

Indexed keywords

BIOLUMINESCENCE; BONE; GENES; PATIENT TREATMENT;

BONE TISSUE ENGINEERING; MOLECULAR IMAGING;

IMAGING TECHNIQUES;

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RESPONSIVE ELEMENT OF THE INHIBITOR OF DIFFERENTIATION PROTEIN GENE; COLECALCIFEROL; COLLAGEN TYPE 1; DEXAMETHASONE; INHIBITOR OF DIFFERENTIATION 2; LUCIFERASE; SIALOPROTEIN; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANGIOGENESIS; APOPTOSIS; ARTHRITIS; BIOLUMINESCENCE; BIOLUMINESCENT IMAGING; BONE REGENERATION; BONE TISSUE; CELL COUNT; CELL DIFFERENTIATION; GENE CONSTRUCT; GENE EXPRESSION; IMAGE ANALYSIS; IMAGING; MEDICAL RESEARCH; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RODENT; SIGNAL TRANSDUCTION; TECHNOLOGY; TISSUE ENGINEERING; TRANSGENIC ANIMAL;

ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, TRANSGENIC; TISSUE ENGINEERING;

ANIMALIA; RODENTIA;

EID: 28744445459     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2005.09.034     Document Type: Review

References (59)

1. M.P. Lutolf, and J.A. Hubbell Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat Biotechnol 23 2005 47 55
2. M.C. Frost, M.M. Reynolds, and M.E. Meyerhoff Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices Biomaterials 26 2005 1685 1693
3. Y. Liu, K. de Groot, and E.B. Hunziker Osteoinductive implants: the mise-en-scene for drug-bearing biomimetic coatings Ann Biomed Eng 32 2004 398 406
4. V. Olivier, N. Faucheux, and P. Hardouin Biomaterial challenges and approaches to stem cell use in bone reconstructive surgery Drug Discov Today 9 2004 803 811
5. X. Liu, and P.X. Ma Polymeric scaffolds for bone tissue engineering Ann Biomed Eng 32 2004 477 486
6. B.C. Heng, T. Cao, L.W. Stanton, P. Robson, and B. Olsen Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro J Bone Miner Res 19 2004 1379 1394
7. M.R. Urist Bone: formation by autoinduction Science 150 1965 893 899
8. S.N. Khan, and J.M. Lane The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications Expert Opin Biol Ther 4 2004 741 748
9. E. Khor, and L.Y. Lim Implantable applications of chitin and chitosan Biomaterials 24 2003 2339 2349
10. K. Shakesheff, S. Cannizzaro, and R. Langer Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules J Biomater Sci Polym Ed 9 1998 507 518
11. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat Biotechnol 19 2001 1029 1034
12. R. Langer, and M. Moses Biocompatible controlled release polymers for delivery of polypeptides and growth factors J Cell Biochem 45 1991 340 345
13. J.M. Bezemer, D.W. Grijpma, P.J. Dijkstra, C.A. van Blitterswijk, and J. Feijen Control of protein delivery from amphiphilic poly(ether ester) multiblock copolymers by varying their water content using emulsification techniques J Control Release 66 2000 307 320
14. D.G. Anderson, S. Levenberg, and R. Langer Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells Nat Biotechnol 22 2004 863 866
15. H. Qi, D.J. Aguiar, S.M. Williams, A. La Pean, W. Pan, and C.M. Verfaillie Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells Proc Natl Acad Sci U S A 100 2003 3305 3310
16. O. Korchynskyi, K.J. Dechering, A.M. Sijbers, W. Olijve, and P. ten Dijke Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation J Bone Miner Res 18 2003 1177 1185
17. S.N. Bailey, D.M. Sabatini, and B.R. Stockwell Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens Proc Natl Acad Sci USA 101 2004 16144 16149
18. H.R. Herschman Molecular imaging: looking at problems, seeing solutions Science 302 2003 605 608
19. A. Maggi, L. Ottobrini, A. Biserni, G. Lucignani, and P. Ciana Techniques: reporter mice - a new way to look at drug action Trends Pharmacol Sci 25 2004 337 342
20. M. Edinger, Y.A. Cao, Y.S. Hornig, D.E. Jenkins, M.R. Verneris, and M.H. Bachmann Advancing animal models of neoplasia through in vivo bioluminescence imaging Eur J Cancer 38 2002 2128 2136
21. A. Honigman, E. Zeira, P. Ohana, R. Abramovitz, E. Tavor, and I. Bar Imaging transgene expression in live animals Mol Ther 4 2001 239 249
22. S. Levenberg, J. Rouwkema, M. Macdonald, E.S. Garfein, D.S. Kohane, and D.C. Darland Engineering vascularized skeletal muscle tissue Nat Biotechnol 23 2005 879 884
23. W. Zhang, J.Q. Feng, S.E. Harris, P.R. Contag, D.K. Stevenson, and C.H. Contag Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression Transgenic Res 10 2001 423 434
24. P. Ciana, M. Raviscioni, P. Mussi, E. Vegeto, I. Que, and M.G. Parker In vivo imaging of transcriptionally active estrogen receptors Nat Med 9 2003 82 86
25. A. Soling, and N.G. Rainov Bioluminescence imaging in vivo - application to cancer research Expert Opin Biol Ther 3 2003 1163 1172
26. P.R. Contag Whole-animal cellular and molecular imaging to accelerate drug development Drug Discov Today 7 2002 555 562
27. A. Wetterwald, G. van der Pluijm, I. Que, B. Sijmons, J. Buijs, and M. Karperien Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease Am J Pathol 160 2002 1143 1153
28. J.S. Blum, J.S. Temenoff, H. Park, J.A. Jansen, A.G. Mikos, and M.A. Barry Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs Biomaterials 25 2004 5809 5819
29. O. Korchynskyi, and P. ten Dijke Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter J Biol Chem 277 2002 4883 4891
30. R.M. Monteiro, S.M. de Sousa Lopes, O. Korchynskyi, P. ten Dijke, and C.L. Mummery Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins J Cell Sci 117 2004 4653 4663
31. T.L. Clemens, H. Tang, S. Maeda, R.A. Kesterson, F. Demayo, and J.W. Pike Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes J Bone Miner Res 12 1997 1570 1576
32. B. Iris, Y. Zilberman, E. Zeira, E. Galun, A. Honigman, and G. Turgeman Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development J Bone Miner Res 18 2003 570 578
33. E.E. Opas, M.A. Gentile, J.A. Rossert, B. de Crombrugghe, G.A. Rodan, and A. Schmidt Parathyroid hormone and prostaglandin E2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-alpha1(I) collagen promoter Bone 26 2000 27 32
34. J.J. Chen, H. Jin, D.M. Ranly, J. Sodek, and B.D. Boyan Altered expression of bone sialoproteins in vitamin D-deficient rBSP2.7Luc transgenic mice J Bone Miner Res 14 1999 221 229
35. J. Chen, J. Sodek, H.F. Thomas, and D.M. Ranly Dexamethasone stimulates luciferase gene expression through the rat bone sialoprotein gene promoter in transgenic mice Connect Tissue Res 35 1996 33 39
36. R. Gopalakrishnan, P.E. Thomas, M.D. Benson, D. Wang, and R.T. Franceschi A homeodomain protein binding element in the bone sialoprotein promoter is critical for tissue-specific expression in bone Connect Tissue Res 44 Suppl 1 2003 154 160
37. R.L. van Bezooijen, B.A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, and M. Karperien Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J Exp Med 199 2004 805 814
38. J.L. Kadurugamuwa, L. Sin, E. Albert, J. Yu, K. Francis, and M. DeBoer Direct continuous method for monitoring biofilm infection in a mouse model Infect Immun 71 2003 882 890
39. H. Carlsen, J.O. Moskaug, S.H. Fromm, and R. Blomhoff In vivo imaging of NF-kappa B activity J Immunol 168 2002 1441 1446
40. N. Zhang, A. Weber, B. Li, R. Lyons, P.R. Contag, and A.F. Purchio An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice J Immunol 170 2003 6307 6319
41. B. Laxman, D.E. Hall, M.S. Bhojani, D.A. Hamstra, T.L. Chenevert, and B.D. Ross Noninvasive real-time imaging of apoptosis Proc Natl Acad Sci U S A 99 2002 16551 16555
42. M. Doubrovin, V. Ponomarev, T. Beresten, J. Balatoni, W. Bornmann, and R. Finn Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo Proc Natl Acad Sci USA 98 2001 9300 9305
43. W. Wang, and W.S. El-Deiry Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model Cancer Biol Ther 2 2003 196 202
44. J.C. Miller, H.H. Pien, D. Sahani, A.G. Sorensen, and J.H. Thrall Imaging angiogenesis: applications and potential for drug development J Natl Cancer Inst 97 2005 172 187
45. K.A. Miles Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76 Spec No. 1 2003 S36 S42
46. N. Zhang, Z. Fang, P.R. Contag, A.F. Purchio, and D.B. West Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood 103 2004 617 626
47. A. Otani, K. Kinder, K. Ewalt, F.J. Otero, P. Schimmel, and M. Friedlander Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis Nat Med 8 2002 1004 1010
48. Y.L. Liu, S.O. Ang, D.A. Weigent, J.T. Prchal, and J.R. Bloomer Regulation of ferrochelatase gene expression by hypoxia Life Sci 75 2004 2035 2043
49. T. Shibata, AJ. Giaccia, and JM. Brown Development of a hypoxia-responsive vector for tumor-specific gene therapy Gene Ther 7 2000 493 498
50. J.E. Mogford, N.K. Roy, K.J. Cross, and T.A. Mustoe Use of hypoxia-inducible factor signal transduction pathway to measure O2 levels and modulate growth factor pathways Wound Repair Regen 11 2003 496 503
51. N. Barker, P.J. Morin, and H. Clevers The Yin-Yang of TCF/beta-catenin signaling Adv Cancer Res 77 2000 1 24
52. S. Jarriault, C. Brou, F. Logeat, E.H. Schroeter, R. Kopan, and A. Israel Signalling downstream of activated mammalian Notch Nature 377 1995 355 358
53. J. De Boer, H.J. Wang, and C. Van Blitterswijk Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells Tissue Eng 10 2004 393 401
54. J. Roose, M. Molenaar, J. Peterson, J. Hurenkamp, H. Brantjes, and P. Moerer The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors Nature 395 1998 608 612
55. R. Rosin-Arbesfeld, A. Cliffe, T. Brabletz, and M. Bienz Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription EMBO J 22 2003 1101 1113
56. R.A. Gibbs, G.M. Weinstock, M.L. Metzker, D.M. Muzny, E.J. Sodergren, and S. Scherer Genome sequence of the Brown Norway rat yields insights into mammalian evolution Nature 428 2004 493 521
57. C. Lois, E.J. Hong, S. Pease, E.J. Brown, and D. Baltimore Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors Science 295 2002 868 872
58. S. Bhaumik, and S.S. Gambhir Optical imaging of Renilla luciferase reporter gene expression in living mice Proc Natl Acad Sci U S A 99 2002 377 382
59. S. Bhaumik, X.Z. Lewis, and S.S. Gambhir Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice J Biomed Opt 9 2004 578 586